Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
Apogee Therapeutics, Inc. (APGE)
Fairmount Funds Management LLC — Director
Shares
1,750,000
Price
$76.30
Total Value
$133.53M
Shares Held After
298,647
% of Holdings
85.4%
Precision BioSciences, Inc. (DTIL)
Amoroso Michael — Director
Shares
34,799
Price
$4.17
Total Value
$145.11K
Shares Held After
196,154
% of Holdings
15.1%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
60,000
Price
$60.23
Total Value
$3.61M
Shares Held After
134,201
% of Holdings
30.9%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
66,477
Price
$29.44
Total Value
$1.96M
Shares Held After
19,820
% of Holdings
77.0%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
10,463
Price
$29.44
Total Value
$308.03K
Shares Held After
86,297
% of Holdings
10.8%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
7,605
Price
$29.44
Total Value
$223.89K
Shares Held After
96,760
% of Holdings
7.3%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
17,236
Price
$29.44
Total Value
$507.43K
Shares Held After
104,365
% of Holdings
14.2%
Edgewise Therapeutics, Inc. (EWTX)
Edris Badreddin — Director
Shares
13,690
Price
$29.44
Total Value
$403.03K
Shares Held After
121,601
% of Holdings
10.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,977
Price
$26.03
Total Value
$51.46K
Shares Held After
197,634
% of Holdings
1.0%
Allogene Therapeutics, Inc. (ALLO)
Roberts Zachary — EVP of R&D
Shares
26,269
Price
$1.56
Total Value
$40.98K
Shares Held After
616,866
% of Holdings
4.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,749
Price
$97.94
Total Value
$367.18K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
553
Price
$95.49
Total Value
$52.81K
Shares Held After
3,749
% of Holdings
12.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
700
Price
$109.84
Total Value
$76.89K
Shares Held After
59,634
% of Holdings
1.2%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — General Counsel
Shares
908
Price
$115.60
Total Value
$104.96K
Shares Held After
46,976
% of Holdings
1.9%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,878
Price
$72.45
Total Value
$208.51K
Shares Held After
31,599
% of Holdings
8.3%
Avidity Biosciences, Inc. (RNAM)
Hughes Steven George — Chief Medical Officer
Shares
2,017
Price
$72.45
Total Value
$146.13K
Shares Held After
34,477
% of Holdings
5.5%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
7,993
Price
$72.45
Total Value
$579.09K
Shares Held After
269,007
% of Holdings
2.9%
Avidity Biosciences, Inc. (RNAM)
Boyce Sarah — Director
Shares
6,394
Price
$72.45
Total Value
$463.25K
Shares Held After
277,000
% of Holdings
2.3%
Avidity Biosciences, Inc. (RNAM)
Flanagan W. Michael — Chief Scientific Officer
Shares
2,558
Price
$72.45
Total Value
$185.33K
Shares Held After
85,093
% of Holdings
2.9%
Avidity Biosciences, Inc. (RNAM)
Flanagan W. Michael — Chief Scientific Officer
Shares
3,976
Price
$72.45
Total Value
$288.06K
Shares Held After
87,651
% of Holdings
4.3%
Avidity Biosciences, Inc. (RNAM)
MacLean Michael F — Chief Financial Officer
Shares
2,735
Price
$72.45
Total Value
$198.15K
Shares Held After
59,290
% of Holdings
4.4%
Avidity Biosciences, Inc. (RNAM)
MacLean Michael F — Chief Financial Officer
Shares
1,807
Price
$72.45
Total Value
$130.92K
Shares Held After
62,025
% of Holdings
2.8%
Avidity Biosciences, Inc. (RNAM)
LEVIN ARTHUR A — Director
Shares
1,758
Price
$72.45
Total Value
$127.37K
Shares Held After
16,562
% of Holdings
9.6%
Avidity Biosciences, Inc. (RNAM)
McCarthy Teresa — Chief Human Resources Officer
Shares
1,453
Price
$72.45
Total Value
$105.27K
Shares Held After
113,938
% of Holdings
1.3%
Avidity Biosciences, Inc. (RNAM)
McCarthy Teresa — Chief Human Resources Officer
Shares
1,476
Price
$72.45
Total Value
$106.94K
Shares Held After
115,391
% of Holdings
1.3%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,247
Price
$1.81
Total Value
$4.06K
Shares Held After
180,686
% of Holdings
1.2%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
2,331
Price
$1.80
Total Value
$4.20K
Shares Held After
256,266
% of Holdings
0.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
2,473
Price
$1.81
Total Value
$4.47K
Shares Held After
306,611
% of Holdings
0.8%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
9,346
Price
$1.81
Total Value
$16.93K
Shares Held After
883,964
% of Holdings
1.0%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
2,315
Price
$1.81
Total Value
$4.18K
Shares Held After
205,554
% of Holdings
1.1%
Axsome Therapeutics, Inc. (AXSM)
Maizel Ari — Chief Commercial Officer
Shares
7,500
Price
$184.44
Total Value
$1.38M
Shares Held After
0
% of Holdings
100.0%
CorMedix Inc. (CRMD)
Dillione Janet — Director
Shares
10,000
Price
$6.88
Total Value
$68.80K
Shares Held After
38,473
% of Holdings
20.6%
Precision BioSciences, Inc. (DTIL)
Scimeca Dario — General Counsel and Secretary
Shares
8,854
Price
$4.03
Total Value
$35.68K
Shares Held After
44,715
% of Holdings
16.5%
Precision BioSciences, Inc. (DTIL)
Kelly John Alexander — Chief Financial Officer
Shares
15,213
Price
$4.03
Total Value
$61.31K
Shares Held After
106,448
% of Holdings
12.5%
Precision BioSciences, Inc. (DTIL)
SMITH J. JEFFERSON — Chief Research Officer
Shares
10,200
Price
$4.03
Total Value
$41.11K
Shares Held After
110,184
% of Holdings
8.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
24,362
Price
$33.80
Total Value
$823.44K
Shares Held After
58,382
% of Holdings
29.4%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
15,422
Price
$33.25
Total Value
$512.78K
Shares Held After
82,744
% of Holdings
15.7%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
265
Price
$5.96
Total Value
$1.58K
Shares Held After
22,580
% of Holdings
1.2%
RenovoRx, Inc. (RNXT)
Agah Ramtin — Director
Shares
10,000
Price
$1.00
Total Value
$9.97K
Shares Held After
798,460
% of Holdings
1.3%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
2,000
Price
$3.00
Total Value
$6.00K
Shares Held After
0
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Chang David J. — Chief Medical Officer
Shares
8,800
Price
$2.26
Total Value
$19.89K
Shares Held After
8,800
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Binder Gwendolyn — President, Science & Tech.
Shares
11,312
Price
$2.19
Total Value
$24.76K
Shares Held After
31,312
% of Holdings
36.1%
Cabaletta Bio, Inc. (CABA)
Tomasello Shawn — Director
Shares
22,725
Price
$2.21
Total Value
$50.32K
Shares Held After
22,725
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Gavel Steve — Chief Commercial Officer
Shares
22,170
Price
$2.27
Total Value
$50.22K
Shares Held After
22,170
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Bollard Catherine — Director
Shares
4,405
Price
$2.27
Total Value
$9.98K
Shares Held After
5,405
% of Holdings
81.5%
Cabaletta Bio, Inc. (CABA)
Nichtberger Steven — Director
Shares
45,000
Price
$2.24
Total Value
$100.78K
Shares Held After
1,031,483
% of Holdings
4.4%
Cabaletta Bio, Inc. (CABA)
Simon Mark — Director
Shares
11,061
Price
$2.28
Total Value
$25.26K
Shares Held After
147,205
% of Holdings
7.5%
Cabaletta Bio, Inc. (CABA)
Gerard Michael — General Counsel
Shares
6,600
Price
$2.27
Total Value
$14.98K
Shares Held After
6,600
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,119
Price
$5.05
Total Value
$61.20K
Shares Held After
617,824
% of Holdings
1.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
300
Price
$1.34
Total Value
$402.00
Shares Held After
268,866
% of Holdings
0.1%
Showing 2201–2250 of 3515 transactions (page 45 of 71)